12552040

Source:http://linkedlifedata.com/resource/pubmed/id/12552040

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005516, umls-concept:C0024485, umls-concept:C0242656, umls-concept:C0906020, umls-concept:C1515364
pubmed:issue	2
pubmed:dateCreated	2003-1-28
pubmed:abstractText	To assess the feasibility of using MRI measurements as a surrogate endpoint for disease progression in a therapeutic trial for AD.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/R01 AG011378-10
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-10331700, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-10680786, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-10714659, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-10715362, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-10953178, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-1202204, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-1407587, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-1586276, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-1734300, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-2183282, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-2748838, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-7058341, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-719462, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-8363449, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-9010004, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-9305341, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-9393512, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-9400851, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-9442345, http://linkedlifedata.com/resource/pubmed/commentcorrection/12552040-9781519
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Dihydropyridines, http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Oximes, http://linkedlifedata.com/resource/pubmed/chemical/milameline
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1526-632X
pubmed:author	pubmed-author:ChaRR, pubmed-author:FelmleeJ PJP, pubmed-author:GraconSS, pubmed-author:HooverT MTM, pubmed-author:JackC RCRJr, pubmed-author:KnopmanDD, pubmed-author:O'BrienP CPC, pubmed-author:PetersenR CRC, pubmed-author:ShiungMM, pubmed-author:SlomkowskiMM, pubmed-author:StewartKK, pubmed-author:XuYY
pubmed:issnType	Electronic
pubmed:day	28
pubmed:volume	60
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	253-60
pubmed:dateRevised	2011-5-27
pubmed:meshHeading	pubmed-meshheading:12552040-Adolescent, pubmed-meshheading:12552040-Adult, pubmed-meshheading:12552040-Aged, pubmed-meshheading:12552040-Aged, 80 and over, pubmed-meshheading:12552040-Alzheimer Disease, pubmed-meshheading:12552040-Biological Markers, pubmed-meshheading:12552040-Brain, pubmed-meshheading:12552040-Dihydropyridines, pubmed-meshheading:12552040-Disease Progression, pubmed-meshheading:12552040-Feasibility Studies, pubmed-meshheading:12552040-Female, pubmed-meshheading:12552040-Hippocampus, pubmed-meshheading:12552040-Humans, pubmed-meshheading:12552040-Magnetic Resonance Imaging, pubmed-meshheading:12552040-Male, pubmed-meshheading:12552040-Middle Aged, pubmed-meshheading:12552040-Muscarinic Agonists, pubmed-meshheading:12552040-Neuroprotective Agents, pubmed-meshheading:12552040-Neuropsychological Tests, pubmed-meshheading:12552040-Oximes, pubmed-meshheading:12552040-Predictive Value of Tests, pubmed-meshheading:12552040-Reference Values, pubmed-meshheading:12552040-Sample Size, pubmed-meshheading:12552040-Sex Distribution, pubmed-meshheading:12552040-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.
pubmed:affiliation	Department of Diagnostic Radiology, Mayo Clinic and Foundation, Rochester, MN, USA. jack.clifford@mayo.edu
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study